JP2009535373A5 - - Google Patents

Download PDF

Info

Publication number
JP2009535373A5
JP2009535373A5 JP2009508294A JP2009508294A JP2009535373A5 JP 2009535373 A5 JP2009535373 A5 JP 2009535373A5 JP 2009508294 A JP2009508294 A JP 2009508294A JP 2009508294 A JP2009508294 A JP 2009508294A JP 2009535373 A5 JP2009535373 A5 JP 2009535373A5
Authority
JP
Japan
Prior art keywords
virus
pharmaceutical composition
composition according
syndrome
influenza
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2009508294A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009535373A (ja
JP5441685B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2007/053574 external-priority patent/WO2007128647A1/en
Publication of JP2009535373A publication Critical patent/JP2009535373A/ja
Publication of JP2009535373A5 publication Critical patent/JP2009535373A5/ja
Application granted granted Critical
Publication of JP5441685B2 publication Critical patent/JP5441685B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2009508294A 2006-05-02 2007-04-12 チモシンα1の、単独またはPTX3またはガンシクロビルとの組合せにおける、サイトメガロウイルス感染の処置のための使用 Expired - Fee Related JP5441685B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP06113401.1 2006-05-02
EP06113401 2006-05-02
PCT/EP2007/053574 WO2007128647A1 (en) 2006-05-02 2007-04-12 USE OF THYMOSIN α1, ALONE OR IN COMBINATION WITH PTX3 OR GANCICLOVIR, FOR THE TREATMENT OF CYTOMEGALOVIRUS INFECTION

Publications (3)

Publication Number Publication Date
JP2009535373A JP2009535373A (ja) 2009-10-01
JP2009535373A5 true JP2009535373A5 (https=) 2010-05-27
JP5441685B2 JP5441685B2 (ja) 2014-03-12

Family

ID=36658736

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009508294A Expired - Fee Related JP5441685B2 (ja) 2006-05-02 2007-04-12 チモシンα1の、単独またはPTX3またはガンシクロビルとの組合せにおける、サイトメガロウイルス感染の処置のための使用

Country Status (18)

Country Link
US (1) US8337828B2 (https=)
EP (1) EP2012816B1 (https=)
JP (1) JP5441685B2 (https=)
KR (1) KR101380360B1 (https=)
CN (1) CN101437535B (https=)
AU (1) AU2007247292B2 (https=)
BR (1) BRPI0711136A2 (https=)
CA (1) CA2649063C (https=)
CY (1) CY1113277T1 (https=)
DK (1) DK2012816T3 (https=)
ES (1) ES2389452T3 (https=)
HR (1) HRP20120676T1 (https=)
MX (1) MX2008013872A (https=)
PL (1) PL2012816T3 (https=)
PT (1) PT2012816E (https=)
RS (1) RS52377B (https=)
SI (1) SI2012816T1 (https=)
WO (1) WO2007128647A1 (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1298487B1 (it) * 1997-12-19 2000-01-10 Sigma Tau Ind Farmaceuti Composizioni farmaceutiche comprendenti pentraxina lunga ptx3 per la terapia di patologie di tipo infettivo, infiammatorio o tumorale,
ITRM20040223A1 (it) * 2004-05-07 2004-08-07 Sigma Tau Ind Farmaceuti Medicamento per il trattamento delle infezioni fungine, in particolare dell'aspergillosi.
EP1832295A1 (en) * 2006-03-10 2007-09-12 Tecnogen S.P.A. Use of PTX3 for the treatment of viral diseases
US8829173B2 (en) * 2008-09-26 2014-09-09 Tocagen Inc. Recombinant vectors
WO2010129947A2 (en) * 2009-05-08 2010-11-11 Sciclone Pharmaceuticals, Inc. Alpha thymosin peptides as vaccine enhancers
US20140213506A1 (en) * 2011-02-09 2014-07-31 Cynthia W. TUTHILL Thymosin alpha peptide for preventing, reducing the severity of, and treating infection
ES2786051T3 (es) 2012-10-25 2020-10-08 Tocagen Inc Vector retroviral con casete de mini-promotor

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6106868A (en) * 1990-08-24 2000-08-22 The Board Of Governors Of Wayne State University Method for the treatment of hepatitis
TW224053B (https=) * 1991-09-13 1994-05-21 Paul B Chretien
CN1072961C (zh) * 1993-03-05 2001-10-17 施塞克龙药品公司 治疗对干扰素治疗无反应者的丙型肝炎的方法
US6200952B1 (en) * 1993-06-02 2001-03-13 Sciclone Pharmaceuticals, Inc. Combination therapy method for treating chronic hepatitis B
US5632983A (en) * 1994-11-17 1997-05-27 University Of South Florida Method for treating secondary immunodeficiency
WO1998018491A1 (en) * 1996-10-28 1998-05-07 BURGSTINER, Jacqueline, Cook Methods and compositions for dietary supplementation
US5939423A (en) * 1997-04-16 1999-08-17 Sciclone Pharmaceuticals, Inc. Treatment of hepatitis B infection with thymosin alpha 1 and famciclovir
IT1298487B1 (it) * 1997-12-19 2000-01-10 Sigma Tau Ind Farmaceuti Composizioni farmaceutiche comprendenti pentraxina lunga ptx3 per la terapia di patologie di tipo infettivo, infiammatorio o tumorale,
US6288033B1 (en) * 1998-09-25 2001-09-11 Sciclone Pharmaceuticals, Inc. Treatment of hepatitis B infection with thymosin alpha 1 in combination with lamivudine or in combination with lamivudine and famciclovir
IT1317927B1 (it) 2000-11-03 2003-07-15 Sigma Tau Ind Farmaceuti Uso della pentraxina lunga ptx3 per la preparazione di un medicamentoper il trattamento di patologie autoimmuni.
IT1317930B1 (it) 2000-11-08 2003-07-15 Sigma Tau Ind Farmaceuti Uso della pentraxina lunga ptx3 per la preparazione di un medicamentoper il trattamento di patalogie associate ad una alterata attivazione
US20040198655A1 (en) 2001-08-03 2004-10-07 Alberto Mantovani Use of long pentraxin ptx3 for treating female infertility
WO2003035111A1 (en) * 2001-10-24 2003-05-01 Sciclone Pharmaceuticals, Inc. Antiretroviral compositions comprising thymosin alpha peptides and protease inhibitors
JP2006524704A (ja) * 2003-04-23 2006-11-02 サイクローン・ファーマシューティカルズ・インコーポレイテッド アルファチモシンペプチドによる呼吸器ウイルス感染の治療または予防
ITRM20030596A1 (it) 2003-12-23 2005-06-24 Sigma Tau Ind Farmaceuti Uso di inibitori della pentraxina lunga ptx3, per la preparazione di un medicamento per la prevenzione e cura di patologie che rispondono all'inibizione dell'attivita' biologica di detta ptx3.
EP1832295A1 (en) * 2006-03-10 2007-09-12 Tecnogen S.P.A. Use of PTX3 for the treatment of viral diseases

Similar Documents

Publication Publication Date Title
JP2009535373A5 (https=)
EP3078377A3 (en) Nitazoxanide and tizoxanide as anti-viral agents
Sureau et al. The hepatitis delta virus: Replication and pathogenesis
JP2016006053A5 (https=)
GB2446721B (en) Herpes simplex viruses and methods of viral replication
WO2009136979A3 (en) Compounds that modulate negative-sense, single-stranded rna virus replication and uses thereof
WO2008019213A3 (en) Use of extracts for the treatment of viral disorders
WO2011041713A3 (en) Piperazinyl antiviral agents
WO2009106019A3 (es) Compuestos quimicos con accion antiviral contra virus dengue y otros flavivirus
CL2012000988A1 (es) Compuestos derivados de biaril purina y 3-deazapurina, moduladores selectivos de los receptores de tipo toll; composicion farmaceutica; y su uso para tratar una infeccion viral y para el tratamiento o la prevencion del melanoma, carcinoma hepatocelular, mieloma, rinitis, asma y fibrosis hepatica, entre otros.
CL2011000136A1 (es) Compuestos derivados de 3-fenilpiridin-2-ona, inhibidores de rna polimerasa dependiente de rna viral; composicion faramceutica que comprende dichos compuestos; y su uso para el tratamiento de una enfermedad causada por el virus de la hepatitis c.
IL186611A0 (en) Vaccine against pandemic strains of influenza viruses
WO2010080032A3 (en) Bead-assisted viral transduction
WO2009035420A8 (en) Monoclonal antibodies specific to hemagglutinin and neuraminidase from influenza virus h5-subtype or n1-subtype and uses thereof
WO2011000566A3 (en) Compounds and pharmaceutical compositions for the treatment of negative-sense ssrna virus infections
PT2700405T (pt) Vírus herpes simplex (hsv) com tropismo modificado, suas utilizações e processo de preparação
WO2010021681A3 (en) Compositions and methods for treatment of viral diseases
EP2399575A3 (en) Methods, uses and compositions for treatment of an infection by a virus of the family of flaviviridae through the farnesoid X receptor (FXR) inhibition
WO2008144584A3 (en) Cysteic acid derivatives of anti-viral peptides
HRP20150430T1 (hr) Lijeäśenje same virusne infekcije hepatitisa b ili kombinirane s delta virusom hepatitisa te povezanih jetrenih bolesti
De Clercq Looking back in 2009 at the dawning of antiviral therapy now 50 years ago: an historical perspective
EA200602289A1 (ru) Применение иматиниба для лечения нарушений работы печени и вирусных инфекций
WO2010107742A3 (en) Methods and compositions of treating a flaviviridae family viral infection
MX2009003336A (es) Agentes policiclicos para el tratamiento de infecciones de virus sincitiales respiratorias.
HRP20120676T1 (hr) Uporaba tiomiozina 1, samog ili u kombinaciji s ptx3 ili ganciklovirom, za liječenje citomegalovirusne infekcije